| Allergic rhinitis and its impact on asthma (ARIA) 2008 J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ... Allergy 63, 8-160, 2008 | 11148* | 2008 |
| Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer WH West, KW Tauer, JR Yannelli, GD Marshall, DW Orr, GB Thurman, ... New England Journal of Medicine 316 (15), 898-905, 1987 | 1525 | 1987 |
| Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs J Bousquet, HJ Schünemann, B Samolinski, P Demoly, ... Journal of Allergy and Clinical Immunology 130 (5), 1049-1062, 2012 | 808 | 2012 |
| GA (2) LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen) J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ... Allergy 63 (Suppl 86), 8-160, 2008 | 490 | 2008 |
| Cytokine dysregulation associated with exam stress in healthy medical students GD Marshall Jr, SK Agarwal, C Lloyd, L Cohen, EM Henninger, GJ Morris Brain, behavior, and immunity 12 (4), 297-307, 1998 | 368 | 1998 |
| Immune system dysregulation during spaceflight: potential countermeasures for deep space exploration missions BE Crucian, A Choukèr, RJ Simpson, S Mehta, G Marshall, SM Smith, ... Frontiers in immunology 9, 1437, 2018 | 311 | 2018 |
| MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ... Allergy 70 (11), 1372-1392, 2015 | 307 | 2015 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 241 | 2023 |
| ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ... Clinical and translational allergy 6 (1), 47, 2016 | 233 | 2016 |
| Stress, immune regulation, and immunity: applications for asthma GD Marshall Jr, SK Agarwal Allergy and asthma proceedings 21 (4), 241, 2000 | 223 | 2000 |
| Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis–a EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement PW Hellings, WJ Fokkens, C Bachert, CA Akdis, T Bieber, I Agache, ... Allergy 72 (9), 1297-1305, 2017 | 190 | 2017 |
| Stress and allergic diseases ND Dave, L Xiang, KE Rehm, GD Marshall Immunology and Allergy Clinics 31 (1), 55-68, 2011 | 186 | 2011 |
| Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction SK AGARWAL, GD MARSHALL Jr Journal of interferon & cytokine research 18 (12), 1059-1068, 1998 | 178 | 1998 |
| Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines SK Agarwal, GD Marshall Jr Journal of Interferon & Cytokine Research 21 (3), 147-155, 2001 | 169 | 2001 |
| MASK 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, ... Clinical and translational allergy 8 (1), 45, 2018 | 167 | 2018 |
| Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 163 | 2020 |
| Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology J Bousquet, PW Hellings, I Agache, F Amat, I Annesi-Maesano, ... Journal of Allergy and Clinical Immunology 143 (3), 864-879, 2019 | 160 | 2019 |
| Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: implications for chronic fatigue syndrome and cancer R Glaser, DA Padgett, ML Litsky, RA Baiocchi, EV Yang, M Chen, PE Yeh, ... Brain, behavior, and immunity 19 (2), 91-103, 2005 | 157 | 2005 |
| Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis SA Brod, GD Marshall Jr, EM Henninger, S Sriram, M Khan, JS Wolinsky Neurology 46 (6), 1633-1638, 1996 | 149 | 1996 |
| Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper J Bousquet, HJ Schünemann, T Zuberbier, C Bachert, ... Allergy 65 (10), 1212-1221, 2010 | 143 | 2010 |
